Research to help the most vulnerable
The RESIST speaker team: Prof. Dr. Thomas Schulz (in the middle) and the two co-speakers Prof. Dr. Gesine Hansen and Prof. Dr. Reinhold Förster
Some people become only mildly ill when they ’catch’ viral or bacterial infections, whereas others are affected much more severely. But what are the reasons for these differences? And how can the course of a disease be predicted and personalized treatments developed?
These questions are being addressed by the RESIST Cluster of Excellence team. This will enable them to help people with a weakened immune system, including newborn babies, the elderly, people with congenital immunodeficiency, those whose immune system is suppressed for therapeutic reasons, and implant users.
Our research programme is for the weakest. The current threat of the corona pandemic clearly shows how important the goals of our Cluster of Excellence RESIST are. We want to better understand the variable susceptibility of individuals to infections in order to protect vulnerable people as well as possible. In view of the dramatic situation, we in RESIST have started our research on SARS-CoV-2 for several month now.
RESIST – News
RESIST team investigates antibiotic resistance
The impact of the COVID-19 pandemic on multidrug-resistant pathogens: How do the hygiene and distance rules introduced due to the pandemic influence the transmission of multidrug-resistant pathogens in hospitals? Professor Dr Marco Galardini and Pro [...]
Fast & Reliable
A new mass spectrometer – funded by RESIST and the MHH – speeds up research. "It's a real workhorse: fast and solid". This is how Professor Dr. Andreas Pich describes the new mass spectrometer of the MHH research facility Proteomics: "We can now inv [...]
Biomedical Data Science
From 30 April to 15 July 2021, graduates of a bachelor's programme in bioscience or medicine can apply for the four-semester Master's programme "Biomedical Data Science". This new RESIST-funded course at the interface between life science, medicine [...]
RESIST team investigates antibiotic resistance
The impact of the COVID-19 pandemic on multidrug-resistant pathogens: How do the hygiene and distance rules introduced due to the pandemic influence the transmission of multidrug-resistant pathogens in hospitals? Professor Dr Marco Galardini and Pro [...]
Fast & Reliable
A new mass spectrometer – funded by RESIST and the MHH – speeds up research. "It's a real workhorse: fast and solid". This is how Professor Dr. Andreas Pich describes the new mass spectrometer of the MHH research facility Proteomics: "We can now inv [...]
Upcoming seminars
Every Thursday (except during school holidays) two RESIST scientists or top-class researchers from external institutions present their work at the RESIST seminar series. The seminars are taking place from 5 to 6 pm. Due to coronavirus pandemic, it is an online-seminar. If you want to take part ple [...]
